John de Caestecker

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

Rebecca C. Fitzgerald, Massimiliano di Pietro, Krish Ragunath et al. · Gut · 2013 · 1.3K citations · Full text

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 655 citations · Full text

Inflammation, Active Luminal Crohn, Anti-tnf Treatment Failure +9

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 385 citations · Full text

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

Cathy Bennett, Nimish Vakil, Jacques Bergman et al. · Gastroenterology · 2012 · 376 citations · Full text

Surgical Oncology, Esophagus, Esophageal Cancer +11

Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial

Janusz Jankowski, John de Caestecker, Sharon Love et al. · The Lancet · 2018 · 259 citations · Full text